Yeager et al v. Innovus Pharmaceuticals, Inc.
Plaintiff: JAMES L YEAGER, MIDWEST RESEARCH LABORATORIES, James L. Yeager and Midwest Research Laboratories, LLC
Defendant: INNOVUS PHARMACEUTICALS and Innovus Pharmaceuticals, Inc.
Case Number: 1:2018cv00397
Filed: January 19, 2018
Court: US District Court for the Northern District of Illinois
Office: Chicago Office
County: Cook
Presiding Judge: Thomas M Durkin
Nature of Suit: Other Fraud
Cause of Action: 28 U.S.C. § 1332
Jury Demanded By: Both
Docket Report

This docket was last retrieved on May 3, 2019. A more recent docket listing may be available from PACER.

Date Filed Document Text
May 3, 2019 Filing 63 MINUTE entry before the Honorable Thomas M. Durkin:Status hearing held on 5/3/2019. The discovery stay is lifted. Defendant's answer to the first amended complaint is to be filed by 5/24/2019. Written discovery is to issue by 8/31/2019. Fact discovery ordered closed by 9/30/2019. Status hearing set for 8/8/2019 at 09:00 AM.Mailed notice (srn, )
May 3, 2019 Filing 62 ATTORNEY Appearance for Plaintiffs Midwest Research Laboratories, LLC, James L. Yeager by John Paul Paleczny, IV (Paleczny, John)
April 18, 2019 Filing 61 MINUTE entry before the Honorable Thomas M. Durkin: Status hearing set for 5/3/2019 at 09:00 AM.Mailed notice (srn, )
April 18, 2019 Filing 60 MINUTE entry before the Honorable M. David Weisman: Magistrate Status hearing held. Plaintiff's counsel advised Defendant and the Court that Plaintiff is not interested in a settlement conference at this time and will proceed forth with discovery. All matters relating to the referral of this case having been resolved, this matter is returned to the District Judge. Referral terminated. Mailed notice (ao,)
April 8, 2019 Filing 59 MINUTE entry before the Honorable M. David Weisman: Magistrate Status hearing held. Parties addressed whether a settlement conference would be productive. For the reasons discussed on the record, the settlement conference set for 4/10/19 is stricken. Status hearing set for 4/18/19 at 9:15 a.m. Mailed notice (ao,)
April 4, 2019 Filing 58 MINUTE entry before the Honorable M. David Weisman: At the parties request, a telephonic status hearing is set for 4/8/19 at 12:00 p.m. to discuss possible issues related to settlement. Any counsel so wishing may appear by phone at the telephonic status hearing. The call-in number for the hearing is 1-877-411-9748 and the passcode is 1814539. Mailed notice (ao,)
March 5, 2019 Opinion or Order Filing 57 ORDER: Magistrate Status hearing held. A settlement conference is set for 4/10/19 at 2:00 p.m. Plaintiffs' settlement letter shall be delivered to Defendant, with a courtesy copy delivered to the Court, in chambers, on or before 3/27/19. Defendant's settlement letter shall be delivered to Plaintiffs, with a courtesy copy delivered to the Court, in chambers, on or before 4/3/19. The parties must also submit their respective documents by email to Proposed_Order_Weisman@ilnd.uscourts.gov. However, please note that settlement letters are not to be filed on the CM-ECF system. Parties have no objection to the Court having ex parte discussions with counsel in advance of the settlement conference if the Court believes such conversations would be warranted. (For further details see order.) Signed by the Honorable M. David Weisman on 3/5/2019. Mailed notice (ao,)
February 25, 2019 Filing 56 MINUTE entry before the Honorable M. David Weisman: This case has been referred to Magistrate Judge Weisman for the purposes of discovery scheduling and supervision and to conduct a settlement conference. Initial status hearing scheduled for 3/5/19 at 9:15 a.m. Prior to the status hearing, the Court specifically requests that counsel consult the Court's standing order. If the parties believe the case is ready for a settlement conference, counsel should have available dates for a settlement conference for all necessary parties in advance of the status hearing, and to the extent possible, consult with opposing counsel in an attempt to identify mutually convenient and feasible dates for the settlement conference. Judge Weisman generally conducts settlement conferences Tuesdays, Wednesdays, Thursdays, and Fridays at either 10:30 a.m. to 12:30 p.m. or 2:00 p.m. to 4:00 p.m. Other dates and times may be available as required by the Court or the parties. If the parties do not wish to set a settlement conference at this time, the parties should be prepared to discuss discovery scheduling and related issues. Mailed notice (ao,)
February 25, 2019 Filing 55 Pursuant to Local Rule 72.1, this case is hereby referred to the calendar of Honorable M. David Weisman for the purpose of holding proceedings related to: settlement conference. All current discovery dates are stayed. The 2/27/2019 status hearing is vacated..(srn, )Mailed notice.
February 22, 2019 Filing 54 NOTICE OF WITHDRAWL by James L. Yeager OF LISA E. CIRCEO, ESQ. (Circeo, Lisa)
February 19, 2019 Filing 53 NOTICE of Service of Responses to Mandatory Initial Discovery (MIDP) , filed by Defendant Innovus Pharmaceuticals, Inc.. (Poell, David)
February 19, 2019 Filing 52 NOTICE of Service of Responses to Mandatory Initial Discovery (MIDP) , filed by Plaintiff James L. Yeager. (Collis, Michael)
February 5, 2019 Filing 51 MEMORANDUM Opinion and Order: Status hearing held on 2/5/2019.For the foregoing reasons, Innovus's motion #37 is denied in part as to its personal jurisdiction argument. The motion is granted in part as to Counts III and IV and denied as to the remaining counts. If Plaintiffs believe they can cure the deficiencies identified in this opinion as to the dismissed counts and allegations, they may move for leave to file an amended complaint on or before February 26, 2019. The motion should attach a redlined comparison between the current complaint and the proposed amended complaint, and it should be supported by a brief of no more than five pages describing how the proposed amended complaint cures the deficiencies in the current complaint. MIDP is due by 2/19/2019. A proposed discovery schedule is to be filed by 2/26/2019. Status hearing set for 2/27/2019 at 09:00 AM. Plaintiff's motion to compel is denied as moot. #45 Signed by the Honorable Thomas M. Durkin on 2/5/2019:Mailed notice(srn, )
January 29, 2019 Filing 50 MINUTE entry before the Honorable Thomas M. Durkin:On the Court's own motion, the 1/31/2019 status hearing is vacated and reset for 2/5/2019 at 09:00 AM.Mailed notice (srn, )
January 23, 2019 Filing 49 RESPONSE by James L. Yeagerin Opposition to MOTION by Defendant Innovus Pharmaceuticals, Inc. to dismiss for lack of jurisdiction pursuant to Fed. R. Civ. P. 12(b)(2) MOTION TO DISMISS FOR FAILURE TO STATE A CLAIM by Defendant Innovus Pharmaceuticals, Inc. pursuant to Fed. R. Civ. P. 12(b)(6) #37 Supplemental (Attachments: #1 Exhibit)(Collis, Michael)
January 15, 2019 Filing 48 CERTIFICATE of Service by Bradley C. Graveline on behalf of Innovus Pharmaceuticals, Inc. (Graveline, Bradley)
December 17, 2018 Filing 47 MINUTE entry before the Honorable Thomas M. Durkin:Plaintiffs' motion to compel or, in the alternative, motion for leave to conduct jurisdictional discovery, R. #45 , is granted. Plaintiffs allege that Defendant published at least one article in Illinois targeted at Illinois residents, and that Defendant may have sold its product to Illinois residents as a result of the advertisements at issue in the complaint. The extent of Defendant's connections with Illinois are not in the record, and the Court requires more information to resolve Defendant's motion to dismiss for lack of personal jurisdiction on the merits. See Evanger's Cat & Dog Food Co., Inc. v. Thixton, 2018 WL 3831505, at *2 (N.D. Ill. Aug. 13, 2018) ("When personal jurisdiction is challenged under Federal Rule of Civil Procedure 12(b)(2) and the material facts necessary to decide on the issue are in dispute, the Court must consider allowing jurisdictional discovery and holding an evidentiary hearing to resolve the dispute."). Defendants are ordered to respond to Plaintiffs' discovery requests (see R. 45-2), by January 14, 2019. Status set for 12/20/18 is reset for 01/31/19 at 9:00 a.m. Mailed notice (srn, )
December 14, 2018 Filing 46 NOTICE of Motion by Michael T. Collis for presentment of motion to compel, #45 before Honorable Thomas M. Durkin on 12/20/2018 at 09:00 AM. (Collis, Michael)
December 14, 2018 Filing 45 MOTION by Plaintiff James L. Yeager to compel Defendant's Responses to Interrogatories, Request for Production of Documents and Request for Admissions Regarding Personal Jurisdiction or in the Alternative Motion for Leave to Conduct Jurisdictional Discovery (Attachments: #1 Exhibit, #2 Exhibit, #3 Exhibit, #4 Text of Proposed Order)(Collis, Michael)
December 12, 2018 Filing 44 REPLY by Defendant Innovus Pharmaceuticals, Inc. to motion to dismiss/lack of jurisdiction,, Motion to Dismiss for Failure to State a Claim, #37 REPLY IN SUPPORT OF ITS MOTION TO DISMISS PLAINTIFFS AMENDED COMPLAINT (Graveline, Bradley)
December 4, 2018 Filing 43 TRANSCRIPT OF PROCEEDINGS held on 10/22/18 before the Honorable Thomas M. Durkin. Status hearing. Order Number: 33062. Court Reporter Contact Information: Laura Renke, OfficialTranscript@gmail.com, 312.435.6053. IMPORTANT: The transcript may be viewed at the court's public terminal or purchased through the Court Reporter/Transcriber before the deadline for Release of Transcript Restriction. After that date it may be obtained through the Court Reporter/Transcriber or PACER. For further information on the redaction process, see the Court's web site at www.ilnd.uscourts.gov under Quick Links select Policy Regarding the Availability of Transcripts of Court Proceedings. Redaction Request due 12/26/2018. Redacted Transcript Deadline set for 1/4/2019. Release of Transcript Restriction set for 3/4/2019. (Renke, Laura)
November 21, 2018 Filing 42 MEMORANDUM by James L. Yeager in Opposition to motion to dismiss/lack of jurisdiction,, Motion to Dismiss for Failure to State a Claim, #37 (Collis, Michael)
November 7, 2018 Filing 41 CERTIFICATE of Service by Plaintiff James L. Yeager of Plaintiffs' Interrogatories, Request for Production of Documents and Request for Admissions Regarding Personal Jurisdiction (Collis, Michael)
October 22, 2018 Filing 40 MINUTE entry before the Honorable Thomas M. Durkin:Status hearing held on 10/22/2018. Plaintiffs' response to defendant's motion to dismiss #37 is due by 11/21/2018. Defendant's reply due by 12/12/2018. Status hearing set for 12/20/2018 at 09:00 AM. The 10/23/2018 notice motion date is vacated. Mailed notice (srn, )
October 18, 2018 Filing 39 NOTICE of Motion by Bradley C. Graveline for presentment of motion to dismiss/lack of jurisdiction,, Motion to Dismiss for Failure to State a Claim, #37 before Honorable Thomas M. Durkin on 10/23/2018 at 09:00 AM. (Graveline, Bradley)
October 18, 2018 Filing 38 MEMORANDUM by Innovus Pharmaceuticals, Inc. in support of motion to dismiss/lack of jurisdiction,, Motion to Dismiss for Failure to State a Claim, #37 (Graveline, Bradley)
October 18, 2018 Filing 37 MOTION by Defendant Innovus Pharmaceuticals, Inc. to dismiss for lack of jurisdiction pursuant to Fed. R. Civ. P. 12(b)(2), MOTION TO DISMISS FOR FAILURE TO STATE A CLAIM by Defendant Innovus Pharmaceuticals, Inc. pursuant to Fed. R. Civ. P. 12(b)(6) (Graveline, Bradley)
October 16, 2018 Filing 36 STATUS Report Joint Status Report by James L. Yeager (Circeo, Lisa)
October 16, 2018 Filing 35 MINUTE entry before the Honorable Thomas M. Durkin:Any party wishing to participate telephonically at the 10/22/2018 status hearing is instructed to call 877-402-9757, access code 4410831, promptly at 9:00 a.m.Mailed notice (srn, )
September 19, 2018 Filing 34 MINUTE entry before the Honorable Thomas M. Durkin:Defendant's agreed motion for extension of time to 10/18/2018 to answer or otherwise plead #32 is granted. The 10/1/2018 status date is vacated and reset for 10/22/2018 at 09:00 AM. No appearance is required on 9/25/2018. Mailed notice (srn, )
September 17, 2018 Filing 33 NOTICE of Motion by Bradley C. Graveline for presentment of motion for extension of time to file answer, #32 before Honorable Thomas M. Durkin on 9/25/2018 at 09:00 AM. (Graveline, Bradley)
September 17, 2018 Filing 32 MOTION by Defendant Innovus Pharmaceuticals, Inc. for extension of time to file answer regarding amended complaint #15 AGREED MOTION FOR EXTENSION OF TIME TO ANSWER OR OTHERWISE RESPOND TO PLAINTIFFS' FIRST AMENDED COMPLAINT (Graveline, Bradley)
September 14, 2018 Filing 31 ATTORNEY Appearance for Defendant Innovus Pharmaceuticals, Inc. by David Mitchell Poell (Poell, David)
August 14, 2018 Filing 30 MINUTE entry before the Honorable Thomas M. Durkin:Defendant's agreed motion for extension of time to 9/20/2018 to answer or otherwise plead #28 is granted. The 8/29/2018 status hearing is vacated and reset for 10/1/2018 at 09:00 AM. No appearance is required on 8/16/2018.Mailed notice (srn, )
August 13, 2018 Filing 29 NOTICE of Motion by Bradley C. Graveline for presentment of motion for extension of time to file answer #28 before Honorable Thomas M. Durkin on 8/16/2018 at 09:00 AM. (Graveline, Bradley)
August 13, 2018 Filing 28 MOTION by Defendant Innovus Pharmaceuticals, Inc. for extension of time to file answer or Otherwise Respond to Plaintiffs' First Amended Complaint (Agreed) (Graveline, Bradley)
June 13, 2018 Filing 27 MINUTE entry before the Honorable Thomas M. Durkin:Agreed motion for extension of time to 8/23/2018 to answer or otherwise plead #25 is granted. Joint status report is now due 8/24/2018. The 6/28/2018 status date is vacated and reset for 8/29/2018 at 09:00 AM. No appearance is required on 6/19/2018. Mailed notice (srn, )
June 6, 2018 Filing 26 NOTICE of Motion by Bradley C. Graveline for presentment of motion for extension of time to file answer, #25 before Honorable Thomas M. Durkin on 6/19/2018 at 09:00 AM. (Graveline, Bradley)
June 6, 2018 Filing 25 MOTION by Defendant Innovus Pharmaceuticals, Inc. for extension of time to file answer regarding amended complaint #15 AGREED MOTION FOR EXTENSION OF TIME TO ANSWER OR OTHERWISE RESPOND TO PLAINTIFFS FIRST AMENDED COMPLAINT (Graveline, Bradley)
May 8, 2018 Filing 24 MINUTE entry before the Honorable Thomas M. Durkin:Defendant's agreed motion for extension of time to 6/21/2018 to answer or otherwise plead #22 is granted. Joint status report is now due by 6/26/2018. The 6/6/2018 status hearing is vacated and reset for 6/28/2018 at 09:00 AM.No appearance is required on 5/10/2018. Mailed notice (srn, )
May 4, 2018 Filing 23 NOTICE of Motion by Bradley C. Graveline for presentment of motion for extension of time to file answer #22 before Honorable Thomas M. Durkin on 5/10/2018 at 09:00 AM. (Graveline, Bradley)
May 4, 2018 Filing 22 MOTION by Defendant Innovus Pharmaceuticals, Inc. for extension of time to file answer AGREED MOTION FOR EXTENSION OF TIME TO ANSWER OR OTHERWISE RESPOND TO PLAINTIFFS FIRST AMENDED COMPLAINT (Graveline, Bradley)
March 21, 2018 Filing 21 MINUTE entry before the Honorable Thomas M. Durkin:Defendant's agreed motion for extension of time to 5/21/2018 to answer the first amended complaint #19 is granted. No appearance is required on 4/2/2018. The 5/2/2018 status date is vacated and reset for 6/6/2018 at 09:00 AM. Joint status report is to be filed by 6/1/2018. Mailed notice (srn, )
March 20, 2018 Filing 20 NOTICE of Motion by Bradley C. Graveline for presentment of motion for extension of time to file answer #19 before Honorable Thomas M. Durkin on 4/2/2018 at 09:00 AM. (Graveline, Bradley)
March 20, 2018 Filing 19 MOTION by Defendant Innovus Pharmaceuticals, Inc. for extension of time to file answer AGREED MOTION FOR EXTENSION OF TIME TO ANSWER OR OTHERWISE RESPOND TO PLAINTIFFS FIRST AMENDED COMPLAINT (Graveline, Bradley)
March 20, 2018 Filing 18 ATTORNEY Appearance for Defendant Innovus Pharmaceuticals, Inc. by Bradley C. Graveline (Graveline, Bradley)
March 2, 2018 Filing 16 SUMMONS Returned Executed by James L. Yeager, Midwest Research Laboratories, LLC as to Innovus Pharmaceuticals, Inc. on 2/27/2018, answer due 3/20/2018. (Berger Zerman, Beth Ann)
March 1, 2018 Filing 17 MINUTE entry before the Honorable Thomas M. Durkin:Midwest Research Lab's motion to withdraw as attorney #13 is granted. Motion hearing held on 3/1/2018. Attorney Timothy John Keiser and Lance D. Northcutt terminated. Joint status report due by 4/26/2018. Status hearing set for 5/2/2018 at 09:00 AM.Mailed notice (srn, )
February 27, 2018 SUMMONS Issued as to Defendant Innovus Pharmaceuticals, Inc. (pg, )
February 26, 2018 Filing 15 AMENDED complaint by James L. Yeager, Midwest Research Laboratories, LLC against Innovus Pharmaceuticals, Inc. (Attachments: #1 Exhibit A)(Circeo, Lisa)
February 23, 2018 Filing 14 NOTICE of Motion by Lance D. Northcutt for presentment of motion to withdraw as attorney #13 before Honorable Thomas M. Durkin on 3/1/2018 at 09:00 AM. (Northcutt, Lance)
February 23, 2018 Filing 13 MOTION by Attorney Lance Northcutt and Timothy Keiser to withdraw as attorney for Midwest Research Laboratories, LLC, James L. Yeager. No party information provided (Northcutt, Lance)
February 21, 2018 Filing 12 ATTORNEY Appearance for Plaintiffs Midwest Research Laboratories, LLC, James L. Yeager by Beth Ann Berger Zerman (Berger Zerman, Beth Ann)
February 8, 2018 Opinion or Order Filing 11 ORDER: Joint status report due by 3/19/2018. Status hearing set for 3/22/2018 at 09:00 AM. Signed by the Honorable Thomas M. Durkin on 2/8/2018:Mailed notice(srn, )
February 6, 2018 Filing 10 MINUTE entry before the Honorable Thomas M. Durkin:Application to appear pro hac vice #9 is granted; Michael T. Collis added for plaintiffs.Mailed notice (srn, )
February 1, 2018 Filing 9 MOTION for Leave to Appear Pro Hac Vice Filing fee $ 150, receipt number 0752-14074596. (Collis, Michael)
February 1, 2018 Filing 8 MINUTE entry before the Honorable Thomas M. Durkin:Application to appear pro hac vice #7 is granted; Attorney Lisa Erickson Circeo for Midwest Research Laboratories, LLC, and for James L. Yeager added. Mailed notice (srn, )
January 31, 2018 Filing 7 MOTION for Leave to Appear Pro Hac Vice Filing fee $ 150, receipt number 0752-14069188. (Circeo, Lisa)
January 22, 2018 Filing 6 NOTICE TO THE PARTIES - The Court is participating in the Mandatory Initial Discovery Pilot (MIDP). The key features and deadlines are set forth in the attached Notice which includes the MIDP Standing Order. Also attached is a checklist for use by the parties. In cases subject to the pilot, all parties must respond to the mandatory initial discovery requests set forth in the Standing Order before initiating any further discovery in this case. Please note: The discovery obligations in the Standing Order supersede the disclosures required by Rule 26(a)(1). Any party seeking affirmative relief must serve a copy of the attached documents (Notice to Parties and the Standing Order) on each new party when the Complaint, Counterclaim, Crossclaim, or Third-Party Complaint is served. (tt, )
January 19, 2018 Filing 5 ATTORNEY Appearance for Plaintiffs MIDWEST RESEARCH LABORATORIES, JAMES L YEAGER by Timothy John Keiser (Keiser, Timothy)
January 19, 2018 Filing 4 ATTORNEY Appearance for Plaintiffs MIDWEST RESEARCH LABORATORIES, JAMES L YEAGER by Robert E Salyer (Salyer, Robert)
January 19, 2018 Filing 3 ATTORNEY Appearance for Plaintiffs MIDWEST RESEARCH LABORATORIES, JAMES L YEAGER by Lance D. Northcutt (Northcutt, Lance)
January 19, 2018 Filing 2 CIVIL Cover Sheet (Northcutt, Lance)
January 19, 2018 Filing 1 COMPLAINT filed by JAMES L YEAGER; Jury Demand. Filing fee $ 400, receipt number 0752-14022041. (Attachments: #1 Exhibit Exhibit 1, #2 Exhibit)(Northcutt, Lance)
January 19, 2018 SUMMONS Issued as to Defendant INNOVUS PHARMACEUTICALS. (kms)
January 19, 2018 CASE ASSIGNED to the Honorable Thomas M. Durkin. Designated as Magistrate Judge the Honorable M. David Weisman. (jjr, )

Access additional case information on PACER

Use the links below to access additional information about this case on the US Court's PACER system. A subscription to PACER is required.

Access this case on the Illinois Northern District Court's Electronic Court Filings (ECF) System

Search for this case: Yeager et al v. Innovus Pharmaceuticals, Inc.
Search News [ Google News | Marketwatch | Wall Street Journal | Financial Times | New York Times ]
Search Web [ Unicourt | Legal Web | Google | Bing | Yahoo | Ask ]
Plaintiff: JAMES L YEAGER
Search News [ Google News | Marketwatch | Wall Street Journal | Financial Times | New York Times ]
Search Finance [ Google Finance | Yahoo Finance | Hoovers | SEC Edgar Filings ]
Search Web [ Unicourt | Justia Dockets | Legal Web | Google | Bing | Yahoo | Ask ]
Plaintiff: MIDWEST RESEARCH LABORATORIES
Search News [ Google News | Marketwatch | Wall Street Journal | Financial Times | New York Times ]
Search Finance [ Google Finance | Yahoo Finance | Hoovers | SEC Edgar Filings ]
Search Web [ Unicourt | Justia Dockets | Legal Web | Google | Bing | Yahoo | Ask ]
Plaintiff: James L. Yeager
Represented By: Timothy John Keiser
Represented By: Michael T. Collis
Represented By: Lisa Erickson Circeo
Represented By: Beth Ann Berger Zerman
Represented By: Lance D. Northcutt
Represented By: Robert E Salyer
Represented By: John Paul Paleczny, IV
Search News [ Google News | Marketwatch | Wall Street Journal | Financial Times | New York Times ]
Search Finance [ Google Finance | Yahoo Finance | Hoovers | SEC Edgar Filings ]
Search Web [ Unicourt | Justia Dockets | Legal Web | Google | Bing | Yahoo | Ask ]
Plaintiff: Midwest Research Laboratories, LLC
Represented By: Timothy John Keiser
Represented By: Michael T. Collis
Represented By: Lance D. Northcutt
Represented By: Lisa Erickson Circeo
Represented By: Beth Ann Berger Zerman
Represented By: Robert E Salyer
Represented By: John Paul Paleczny, IV
Search News [ Google News | Marketwatch | Wall Street Journal | Financial Times | New York Times ]
Search Finance [ Google Finance | Yahoo Finance | Hoovers | SEC Edgar Filings ]
Search Web [ Unicourt | Justia Dockets | Legal Web | Google | Bing | Yahoo | Ask ]
Defendant: INNOVUS PHARMACEUTICALS
Search News [ Google News | Marketwatch | Wall Street Journal | Financial Times | New York Times ]
Search Finance [ Google Finance | Yahoo Finance | Hoovers | SEC Edgar Filings ]
Search Web [ Unicourt | Justia Dockets | Legal Web | Google | Bing | Yahoo | Ask ]
Defendant: Innovus Pharmaceuticals, Inc.
Represented By: David Mitchell Poell
Represented By: Bradley C. Graveline
Search News [ Google News | Marketwatch | Wall Street Journal | Financial Times | New York Times ]
Search Finance [ Google Finance | Yahoo Finance | Hoovers | SEC Edgar Filings ]
Search Web [ Unicourt | Justia Dockets | Legal Web | Google | Bing | Yahoo | Ask ]

Disclaimer: Justia Dockets & Filings provides public litigation records from the federal appellate and district courts. These filings and docket sheets should not be considered findings of fact or liability, nor do they necessarily reflect the view of Justia.


Why Is My Information Online?